| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/01/2006 | US20060116383 Integrin antagonists useful as anticancer agents |
| 06/01/2006 | US20060116369 Certain compounds, compositions, and methods |
| 06/01/2006 | US20060116364 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer |
| 06/01/2006 | US20060116326 Benzothiophene compounds having antiinfective activity |
| 06/01/2006 | US20060114552 Fluorinated crosslinked electro-optic materials and electro-optic devices therefrom |
| 06/01/2006 | CA2587888A1 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/01/2006 | CA2586972A1 Cycloalkyl piperidine tachykinin receptor antagonists |
| 05/31/2006 | EP1661895A1 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione,maleic acid salt,hydrate as pharmaceutical |
| 05/31/2006 | EP1661890A1 Ppar-activating compound and pharmaceutical composition containing same |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660494A2 Thiazoles as inhibitors of the alk-5 receptor |
| 05/31/2006 | EP1660493A1 Peptidyl heterocyclic ketone derivatives and preparation processes |
| 05/31/2006 | EP1660492A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 05/31/2006 | EP1660491A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 05/31/2006 | EP1660490A1 Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 05/31/2006 | EP1660487A1 Pyrrole compositions useful as inhibitors of c-met |
| 05/31/2006 | EP1660486A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 05/31/2006 | EP1660481A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 05/31/2006 | EP1660478A1 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660465A2 Process for the synthesis of biaryl oxazolidinones |
| 05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 05/31/2006 | EP1660452A1 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 05/31/2006 | EP1660447A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660090A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 05/31/2006 | EP1660087A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 05/31/2006 | EP1556356B1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1319039B1 Pyrimidine derivatives as hardness stabilizers |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1315500A4 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 05/31/2006 | EP1296967B1 Benzothiazolyl ppar-gamma modulators |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | CN1780832A 5-phenylthiazole derivatives and their use as PI3 kinase inhibitors |
| 05/31/2006 | CN1780831A 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 05/31/2006 | CN1780823A Heteroaromatic pentacyclic compound and medicinal use thereof |
| 05/31/2006 | CN1780822A Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (MPO) |
| 05/31/2006 | CN1780819A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 05/31/2006 | CN1778801A Quinolone7-((4-((Z)-2-(2-amino-4-thiazyl)-2- methoxy imino acetyl)-1-piperazine) compound |
| 05/31/2006 | CN1257895C Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053106 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 05/30/2006 | US7053105 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 05/30/2006 | US7053095 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053078 Serine protease inhibitors |
| 05/30/2006 | US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/30/2006 | CA2398159C Sulphonylaminocarbonyltriazolinones having substitutents bonded via oxygen |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/26/2006 | WO2006055725A2 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | WO2006054700A1 Optical filter |
| 05/26/2006 | WO2006054652A1 Amide compound |
| 05/26/2006 | WO2006053748A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 05/26/2006 | WO2006029179A3 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 05/26/2006 | CA2588776A1 Substituted amino carboxylic acids |
| 05/26/2006 | CA2588766A1 Heterocycle substituted carboxylic acids |
| 05/26/2006 | CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/26/2006 | CA2587533A1 Amide derivatives, their manufacture and use as pharmaceutical agents |
| 05/26/2006 | CA2587511A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 05/26/2006 | CA2584619A1 Amide compound |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111408 Therapeutic benzothiazole compounds |
| 05/25/2006 | US20060111377 Heterocyclic derivatives |
| 05/25/2006 | US20060111359 enzyme inhibitor for treating sleep disorders |
| 05/25/2006 | US20060111355 6-({(2S)-4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]-2-methylpiperazin-1-yl}methyl)quinoxaline; orally bioavailable; prostate cancer, endometriosis, uterine fibroids, uterine cancer, breast cancer, ovarian cancer, testicular cancer, primary hirsutism, or LH surge |
| 05/25/2006 | US20060111353 2-Cyclohexyl-1-(4-methanesulfonyl-phenyl)-cyclopropanecarboxylic acid 5-chloro-thiazol-2-yl)-amide; antidiabetic agents; non-insulin dependent diabetes; disorders associated with GK dysfunction; an enhanced solubility profile; improved metabolic stability; increased insulin secretion |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658288A1 2-amino-5-benzoylthiazole npy antagonists |
| 05/24/2006 | EP1658286A1 N-aryl-2-cyanooxazolidinones and their derivatives |
| 05/24/2006 | EP1658272A1 Novel gamma-secretase inhibitors |
| 05/24/2006 | EP1658270A1 Novel 6-phenylphenantridines |
| 05/24/2006 | EP1658267A2 Inhibitors of cathepsin s |
| 05/24/2006 | EP1658071A2 Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/24/2006 | EP1549639B1 Sulphonamide derivatives as antipsychotic agents |
| 05/24/2006 | EP1539723B1 Novel use of benzothiazole derivatives |
| 05/24/2006 | EP1501812A4 Pna monomer and precursor |
| 05/24/2006 | EP1254904B1 Novel piperidine compounds and drugs containing the same |
| 05/24/2006 | DE102004055998A1 Niedermolekulare Inhibitoren von Guaninnucleotid-Austauschfaktoren der Cytohesin-Familie Small-molecule inhibitors of guanine nucleotide exchange factors of the cytohesin family |
| 05/24/2006 | CN1777596A Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 05/24/2006 | CN1777593A Acylaminothiazole derivatives, their preparation and their use as beta starchy peptide to produce inhibitor |
| 05/24/2006 | CN1777592A Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives |
| 05/24/2006 | CN1777582A Substituted indoline and indole derivatives |
| 05/24/2006 | CN1777427A Aminoheteroaryl compounds as protein kinase inhibitors |